Related Experiment Video
Updated: Sep 17, 2025

05:58
Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment
Published on: March 11, 2021
4.7K
Enhanced Handwriting Kinematic Modeling for Alzheimer's Disease Classification Using Machine Learning Models.
Rohith R1, Sakthi Jaya Sundar Rajasekar2, Thangavel Murugan3
1Department of Information Science and Technology, College of Engineering, Guindy Campus, Anna University, Chennai, India.
Studies in Health Technology and Informatics
|July 1, 2025
Summary
Handwriting analysis using machine learning (ML) shows high accuracy in detecting Alzheimer's Disease (AD). This non-intrusive method offers a promising approach for early screening and prognosis evaluation of AD.
Area of Science:
- Neurology
- Computer Science
- Biomedical Engineering
Background:
- Alzheimer's Disease (AD) is a progressive neurodegenerative disorder impacting cognitive and motor functions.
- Handwriting impairment is a recognized symptom of AD, affecting fine motor control and cognitive processing.
Purpose of the Study:
- To investigate the efficacy of handwriting analysis for Alzheimer's Disease detection using Machine Learning (ML).
- To evaluate the performance of various ML models in classifying AD based on handwriting characteristics.
Main Methods:
- A dataset of handwriting samples was collected and preprocessed.
- Data balancing was achieved using normalization and Synthetic Minority Over-Sampling Technique (SMOTE).
- Multiple Machine Learning models, including Multi-Layer Perceptron (MLP), were trained and assessed.
Main Results:
- The Multi-Layer Perceptron (MLP) model achieved a classification accuracy of 99.26%.
- The study demonstrated the potential of ML in identifying AD through handwriting analysis.
Conclusions:
- Handwriting analysis, enhanced by ML, presents a highly accurate and non-intrusive method for AD screening.
- This approach can aid in the early detection and prognosis evaluation of Alzheimer's Disease.
Keywords:
Alzheimer’s DiseaseArtificial IntelligenceHandwriting AnalysisMachine LearningMulti-Layer PerceptronNeurodegenerative disordersMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

